OpenLB
Open Library of Bioscience

Volatilome: A Novel Tool for Risk Scoring in Ischemic Heart Disease.

Abstract

Keywords

References

1. Tsao C.W.; Aday A.W.; Almarzooq Z.I.; Heart Disease and Stroke Statistics—2023 Update: A report From the American Heart Association. Circulation 2023,147(8),e93-e621 [DOI: 10.1161/CIR.0000000000001123]
2. Dorresteijn J.A.N.; Visseren F.L.J.; Wassink A.M.J.; Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: The SMART risk score. Heart 2013,99(12),866-872 [DOI: 10.1136/heartjnl-2013-303640]
3. Visseren F.L.J.; Mach F.; Smulders Y.M.; 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021,42(34),3227-3337 [DOI: 10.1093/eurheartj/ehab484]
4. de Vries T.I.; Cooney M.T.; Selmer R.M.; SCORE2-OP risk prediction algorithms: Estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 2021,42(25),2455-2467 [DOI: 10.1093/eurheartj/ehab312]
5. Hageman S.; Pennells L.; Ojeda F.; SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021,42(25),2439-2454 [DOI: 10.1093/eurheartj/ehab309]
6. Nurmohamed N.S.; Kraaijenhof J.M.; Mayr M.; Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J 2023,44(18),1594-1607 [DOI: 10.1093/eurheartj/ehad161]
7. Močnik M.; Marčun Varda N.; Lipid biomarkers and atherosclerosis—old and new in cardiovascular risk in childhood. Int J Mol Sci 2023,24(3),2237 [DOI: 10.3390/ijms24032237]
8. Marzoog B.A.; Endothelial dysfunction under the scope of arterial hypertension, coronary heart disease, and diabetes mellitus using the angioscan. Cardiovasc Hematol Agents Med Chem 2024,22(2),181-186 [DOI: 10.2174/0118715257246589231018053646]
9. Marzoog B.A.; Vlasova T.I.; Membrane lipids under norm and pathology. European J Clin Exp Med 2021,19(1),59-75 [DOI: 10.15584/ejcem.2021.1.9]
10. Marzoog B.A.; Tree of life: Endothelial cell in norm and disease, the good guy is a partner in crime! Anat Cell Biol 2023,56(2),166-178 [DOI: 10.5115/acb.22.190]
11. Zhu D.; Vernon S.T.; D’Agostino Z.; Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort. Biomolecules 2023,13(6),917 [DOI: 10.3390/biom13060917]
12. Dugani S.B.; Moorthy M.V.; Li C.; Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol 2021,6(4),437-447 [DOI: 10.1001/jamacardio.2020.7073]
13. Marzoog B.A.; Recent advances in molecular biology of metabolic syndrome pathophysiology: Endothelial dysfunction as a potential therapeutic target. J Diabetes Metab Disord 2022,21(2),1903-1911 [DOI: 10.1007/s40200-022-01088-y]
14. Marzoog B.A.; Endothelial cell autophagy in the context of disease development. Anat Cell Biol 2023,56(1),16-24 [DOI: 10.5115/acb.22.098]
15. Marzoog B.; Breathomics detect the cardiovascular disease: Delusion or dilution of the metabolomic signature. Curr Cardiol Rev 2024,20(4),e020224226647 [DOI: 10.2174/011573403X283768240124065853]
16. Abdullah Marzoog B.; Caveolae’s behavior in norm and pathology. Emir Med J 2023,4(2),e080523216639 [DOI: 10.2174/0250688204666230508112229]
17. Marzoog B.A.; The metabolic syndrome puzzles; possible pathogenesis and management. Curr Diabetes Rev 2023,19(4),e290422204258 [DOI: 10.2174/1573399818666220429100411]
18. Kist J.M.; Vos R.C.; Mairuhu A.T.A.; SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: An external validation study. EClinMed 2023,57,101862 [DOI: 10.1016/j.eclinm.2023.101862]
19. Brunström M.; Andersson J.; Eliasson M.; Fu M.; Hansson P-O.; Söderberg S.; SCORE2 - an updated model for cardiovascular risk prediction Lakartidningen 2021,2021,118
20. Yari A; Ueda P; Hagstrom E; Distribution of cardiovascular disease risk according to SCORE2 and potential need for cholesterol and blood pressure lowering therapy in apparently healthy middle-aged individuals Eur Heart J 2022,43(Suppl. 2),ehac544.2279 [DOI: 10.1093/eurheartj/ehac544.2279]
21. Marzoog B.A.; Abdullaev M.; Suvorov A.; Single channel electrocardiography optimizes the diagnostic accuracy of bicycle ergometry! medRxiv 2024 [DOI: 10.1101/2024.04.20.24306122]
22. Kasim SS; Ibrahim N; Malek S; Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health - Western Pac 2023,35,100742 [DOI: 10.1016/j.lanwpc.2023.100742]

MeSH Term

Chemicals